FHTX: Foghorn Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 249.63
Enterprise Value ($M) 188.61
Book Value ($M) -61.65
Book Value / Share -1.11
Price / Book -4.05
NCAV ($M) -94.93
NCAV / Share -1.70
Price / NCAV -2.63

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.32
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.16
Current Ratio 3.16

Balance Sheet (mrq) ($M)
Current Assets 225.42
Assets 258.69
Liabilities 320.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 22.60
Operating Income -100.28
Net Income -86.62

Cash Flow Statement (mra) ($M)
Cash From Operations -100.41
Cash from Investing -29.90
Cash from Financing 105.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Fmr Llc 10.20 -9.73
10-08 13G/A Klarman Family Foundation 3.90
09-20 13G Flynn James E 5.31
2024-05-30 13G Biotechnology Value Fund L P 9.99
2024-05-24 13D/A Flagship Ventures Fund V, L.P. 22.90 28.64

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 20,914 67,275 31.09
2025-06-05 18,313 80,347 22.79
2025-06-04 126,815 220,971 57.39
2025-06-03 32,109 69,137 46.44
2025-06-02 28,428 106,717 26.64

(click for more detail)

Similar Companies
ETNB – 89bio, Inc. ETON – Eton Pharmaceuticals, Inc.
FATE – Fate Therapeutics, Inc. FOLD – Amicus Therapeutics, Inc.
FULC – Fulcrum Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io